| scholarly article | Q13442814 |
| P2093 | author name string | Carlton Haywood | |
| Sophie Lanzkron | |||
| C Patrick Carroll | |||
| P2860 | cites work | Impact of intercensal population projections and error of closure on breast cancer surveillance: examples from 10 California counties | Q24813475 |
| Improved survival of children and adolescents with sickle cell disease | Q33839801 | ||
| The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up | Q33890227 | ||
| Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment | Q34187983 | ||
| An analysis of the root causes for opioid-related overdose deaths in the United States. | Q34192078 | ||
| Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. | Q36573473 | ||
| NIH consensus development statement on hydroxyurea treatment for sickle cell disease. | Q37097875 | ||
| Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders. | Q37360790 | ||
| Acute care utilization and rehospitalizations for sickle cell disease | Q38374639 | ||
| Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients | Q38471171 | ||
| Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting | Q39378138 | ||
| The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). | Q43244775 | ||
| Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. | Q51946241 | ||
| Frequent and prolonged hospitalizations: a risk factor for early mortality in sickle cell disease patients. | Q53395813 | ||
| Mortality in sickle cell disease. Life expectancy and risk factors for early death. | Q55065788 | ||
| Newborn screening coupled with comprehensive follow-up reduced early mortality of sickle cell disease in Connecticut | Q79746055 | ||
| Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance | Q81682302 | ||
| The number of people with sickle-cell disease in the United States: national and state estimates | Q82320507 | ||
| Population estimates of sickle cell disease in the U.S. | Q83889628 | ||
| P433 | issue | 2 | |
| P921 | main subject | sickle-cell disease | Q185034 |
| P304 | page(s) | 110-116 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Public Health Reports | Q15761421 |
| P1476 | title | Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. | |
| P478 | volume | 128 |
| Q90727840 | A CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders within the sickle cell disease community |
| Q50208774 | A Multidisciplinary Approach to Impact Acute Care Utilization in Sickle Cell Disease |
| Q27024148 | A biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical care |
| Q91941555 | A pilot test of the Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me) and the Jenerette Self-Care Assessment (J-SAT) Tools in adults with sickle cell disease |
| Q39269713 | A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia |
| Q28088552 | Advances in sickle cell therapies in the hydroxyurea era |
| Q93066688 | Advancing the science of patient input throughout the regulatory decision-making process |
| Q90460184 | Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease |
| Q38920191 | Allogeneic stem cell transplantation for sickle cell disease |
| Q47614537 | Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia |
| Q89777073 | Alternative donor hematopoietic stem cell transplantation for sickle cell disease |
| Q91639061 | American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease |
| Q38169000 | An intervention to decrease stigma in young adults with sickle cell disease. |
| Q33910633 | Application of a proactive risk analysis to emergency department sickle cell care |
| Q48318556 | Automated red blood cell exchange in preparation for filgrastim mobilization of autologous peripheral blood hematopoietic progenitor cells in a patient with sickle cell anemia. |
| Q64064319 | Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: The emergency department providers' perspective |
| Q88916011 | Barriers to Care for Persons With Sickle Cell Disease: The Case Manager's Opportunity to Improve Patient Outcomes |
| Q64290977 | Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study |
| Q64085639 | CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool |
| Q55262636 | Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth. |
| Q47655526 | Chronic organ failure in adult sickle cell disease. |
| Q33552132 | Comorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES Project |
| Q91681227 | Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled Trial |
| Q35927743 | Comparing segmented ASL perfusion of vascular territories using manual versus semiautomated techniques in children with sickle cell anemia |
| Q36614399 | Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008. |
| Q91771324 | Depression among Sickle Cell Anemia Patients in the Eastern Province of Saudi Arabia |
| Q89777343 | Disease severity and slower psychomotor speed in adults with sickle cell disease |
| Q93179006 | Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study |
| Q92410598 | Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial |
| Q38164192 | Emerging science of hydroxyurea therapy for pediatric sickle cell disease |
| Q38799393 | Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach |
| Q30489282 | Evaluation of a Sickle Cell Disease Educational Website for Emergency Providers. |
| Q36588781 | Exploring Adult Care Experiences and Barriers to Transition in Adult Patients with Sickle Cell Disease |
| Q90619189 | Factors Influencing Motivation and Engagement in Mobile Health Among Patients With Sickle Cell Disease in Low-Prevalence, High-Income Countries: Qualitative Exploration of Patient Requirements |
| Q47414215 | Genome Editing for the β-Hemoglobinopathies |
| Q99711849 | Geriatric assessment for older adults with sickle cell disease: protocol for a prospective cohort pilot study |
| Q92809941 | Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease |
| Q90727421 | HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol |
| Q92023521 | Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell disease |
| Q36038875 | Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions |
| Q41661793 | Hemoglobin disorders |
| Q92420295 | Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease |
| Q92145311 | Hospital Readmission of Adolescents and Young Adults With Complex Chronic Disease |
| Q38692796 | Hydroxyurea (hydroxycarbamide) for sickle cell disease. |
| Q39268375 | Hydroxyurea effectiveness in children and adolescents with sickle cell anemia: A large retrospective, population-based cohort |
| Q35843842 | Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia |
| Q64063197 | Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice |
| Q91813117 | Impact of A Six Week Training Program on Ventilatory Efficiency, Red Blood Cell Rheological Parameters and Red Blood Cell Nitric Oxide Signaling in Young Sickle Cell Anemia Patients: A Pilot Study |
| Q90740839 | Innovations in Targeted Anti-Adhesion Treatment for Sickle Cell Disease |
| Q50204137 | Is transplantation an alternative to the transfusional impasse in sickle cell disease? |
| Q92504054 | Keys to Recruiting and Retaining Seriously Ill African Americans With Sickle Cell Disease in Longitudinal Studies: Respectful Engagement and Persistence |
| Q52842165 | Kidney Transplantation From a Donor With Sickle Cell Disease. |
| Q50667811 | Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice. |
| Q64108860 | Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France |
| Q36091274 | Low forced expiratory volume is associated with earlier death in sickle cell anemia |
| Q36913577 | Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication |
| Q37683303 | Mortality by sickle cell disease in Brazil |
| Q35856569 | Mortality of New York children with sickle cell disease identified through newborn screening |
| Q90029430 | New insights into the pathophysiology and development of novel therapies for sickle cell disease |
| Q36870605 | Nonhematopoietic Nrf2 dominantly impedes adult progression of sickle cell anemia in mice. |
| Q41576877 | Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. |
| Q50117816 | Organ damage mitigation with the Baskent Sickle Cell Medical Care Development Program (BASCARE). |
| Q59756229 | Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California |
| Q64264766 | Outcome of cranial surgery in Nigerian patients with hemoglobinopathies: A retrospective study |
| Q90707784 | Paediatric to adult transition care for patients with sickle cell disease: a global perspective |
| Q38814652 | Pediatric sickle cell disease: past successes and future challenges |
| Q89777263 | Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review |
| Q49985049 | Phytomedicines (medicines derived from plants) for sickle cell disease. |
| Q37049545 | Pregnancy in Sickle Cell Disease Is a Very High-Risk Situation: An Observational Study |
| Q57158621 | Preliminary exploration of secondhand smoke exposure in youth with Sickle Cell Disease: biochemical verification, pulmonary functioning, and health care utilization |
| Q48140774 | Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study |
| Q37228158 | Psychometric Properties of the Psychosocial Assessment Tool-General in Adolescents and Young Adults With Sickle Cell Disease. |
| Q100680659 | Racial inequalities in access to care for young people living with pain due to sickle cell disease |
| Q89112351 | Red Blood Cell Adhesion to Heme-Activated Endothelial Cells Reflects Clinical Phenotype in Sickle Cell Disease |
| Q90630572 | Reducing Health Care Disparities in Sickle Cell Disease: A Review |
| Q33574142 | Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe |
| Q33690218 | Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease |
| Q92420886 | Shared Care for Adults with Sickle Cell Disease: An Analysis of Care from Eight Health Systems |
| Q90598059 | Sickle Cell Disease: Advances in Treatment |
| Q37585014 | Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. |
| Q37258558 | Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology |
| Q87152144 | Sickle cell disease is not so benign |
| Q52795486 | Sickle cell disease. |
| Q53774753 | Sickle cell disease. |
| Q48174073 | Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease |
| Q55053106 | Sickle cell disease: a natural model of acute and chronic pain. |
| Q40411281 | Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation |
| Q40081852 | Significance of electronic health records: A comparative study of vaccination rates in patients with sickle cell disease |
| Q92579133 | The Anticipatory Politics of Improving Childhood Survival for Sickle Cell Disease |
| Q42109748 | The Opioid Drug Epidemic and Sickle Cell Disease: Guilt by Association |
| Q41138217 | The effect of hypnosis on pain and peripheral blood flow in sickle-cell disease: a pilot study |
| Q88043741 | Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease |
| Q91714125 | Transition to adult care in sickle cell disease: A longitudinal study of clinical characteristics and disease severity |
| Q37442387 | Translating sickle cell guidelines into practice for primary care providers with Project ECHO. |
| Q35054855 | Trends in mortality and hospital admissions of sickle cell disease patients before and after the newborn screening program in Maranhão, Brazil |
| Q47559451 | Twelve tips for teaching a comprehensive disease-focused course with a global perspective: A sickle cell disease example |
| Q38850483 | Use of genome-editing tools to treat sickle cell disease |
| Q49989050 | What is the role of screening for pulmonary hypertension in adults and children with sickle cell disease? |
| Q90224995 | Why, Who, When, and How? Rationale for Considering Allogeneic Stem Cell Transplantation in Children with Sickle Cell Disease |
| Q36543928 | Youth with Sickle Cell Disease: Genetic and Sexual Health Education Needs. |
| Q85472490 | [Myocardial function and endothelial dysfunction in sickle cell anemia] |
Search more.